You can buy or sell Danaher and other stocks, options, ETFs, and crypto commission-free!
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Read More The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
Washington, District of Columbia
52 Week High
52 Week Low
BRIEF-Danaher Says Priced A Reopening Of EUR 150 Mln Of Additional 1.700% Senior Notes Due 2024 At An Offering Price Of 100.298%
April 3 (Reuters) - Danaher Corp: * DANAHER PRICES REOPENING OF EURO-DENOMINATED SENIOR NOTES * DANAHER CORP - PRICED A REOPENING OF EUR 150 MILLION OF ADDITI
Danaher Prices Reopening Of Euro-Denominated Senior Notes
WASHINGTON, April 3, 2020 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced a reopening of: €150,000,000 principal
— per share
Expected Apr 16, Pre-Market